Krystal Biotech

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.

CEO

Krish S. Krishnan

CEOKrish S. Krishnan

Employees

275

Employees275

Headquarters

Pittsburgh, Pennsylvania

HeadquartersPittsburgh, Pennsylvania

Founded

2016

Founded2016

Employees

275

Employees275

KRYS Key Statistics

Market cap

5.45B

Market cap5.45B

Price-Earnings ratio

39.26

Price-Earnings ratio39.26

Dividend yield

—

Dividend yield—

Average volume

277.34K

Average volume277.34K

High today

$195.91

High today$195.91

Low today

$187.53

Low today$187.53

Open price

$193.41

Open price$193.41

Volume

238.21K

Volume238.21K

52 Week high

$207.84

52 Week high$207.84

52 Week low

$122.80

52 Week low$122.80

KRYS News

Simply Wall St 2d

Krystal Biotech And 2 More Growth Stocks With Significant Insider Ownership

As the U.S. stock market experiences a mix of volatility and upward momentum, driven by strong bank earnings and fluctuating trade tensions with China, investor...

TipRanks 3d

Krystal Biotech gets FDA platform technology designation to HSV-1 viral vector

Krystal Biotech (KRYS) announced that the United States Food and Drug Administration granted platform technology designation to the genetically modified, non-re...

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…